$4.99
-0.15-2.92%
Pre-Market: Feb 25, 8:41 AM EDT
Comments
Loading...
Neuphoria Therapeutics Stock Guidance | NASDAQ:NEUP | Benzinga
Neuphoria Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for Neuphoria Therapeutics (NEUP)?
There have been no specific sales or earnings guidance reported for Neuphoria Therapeutics in recent months.
Browse guidance and forecast on all stocks.